Diagnosis and Management of Gastroesophageal Reflux Disease (GERD)

Initial Clinical Assessment

The American Gastroenterological Association recommends that patients with typical reflux symptoms (heartburn and regurgitation) without alarm features can be diagnosed clinically and treated empirically with a proton pump inhibitor (PPI) trial for 4-8 weeks 1, 2
Alarm symptoms requiring immediate endoscopy include dysphagia, bleeding, anemia, weight loss, and recurrent vomiting, as recommended by the American College of Physicians 3

For patients with typical esophageal symptoms, the American Gastroenterological Association suggests starting with a single-dose PPI therapy for 4-8 weeks, and if partial response, escalate to twice-daily PPI dosing for an additional 4-8 weeks 1, 2
For patients with extraesophageal symptoms, the American Gastroenterological Association recommends performing upfront objective reflux testing off medication rather than an empiric PPI trial 4, 5, 6

The American Society for Gastrointestinal Endoscopy recommends upper endoscopy (EGD) for patients with alarm symptoms, typical GERD symptoms persisting despite 4-8 weeks of twice-daily PPI therapy, and men older than 50 years with chronic GERD symptoms and additional risk factors 3
The American Gastroenterological Association suggests that wireless pH monitoring (96-hour) is the preferred method for ambulatory reflux monitoring when available, and should be performed off PPI therapy to objectively assess acid exposure time (AET) 1

The American College of Gastroenterology recommends that a confirmed GERD diagnosis can be made with the presence of Los Angeles Grade B or higher esophagitis on endoscopy, or AET >4.0% on at least 1 day of wireless pH monitoring 1
The American Gastroenterological Association suggests that borderline GERD can be diagnosed with Los Angeles Grade A esophagitis and/or elevated AET not meeting full GERD criteria 1

The American Gastroenterological Association recommends that objective documentation of pathologic GERD is mandatory before anti-reflux surgery, and requires confirmatory evidence of pathologic GERD, exclusion of achalasia, and assessment of esophageal peristaltic function with high-resolution manometry 1, 6

The American Gastroenterological Association suggests that heartburn and acid regurgitation are the cardinal symptoms of GERD 7

The American College of Gastroenterology recommends initiating a therapeutic trial of twice-daily full-dose PPI for 4 weeks as the first diagnostic step, with a positive trial requiring at least 75% reduction in symptom frequency 7
Objective testing, such as pH monitoring or endoscopy, should be pursued only in specific scenarios, including before antireflux surgery, when symptoms don't respond to PPI, or when extraesophageal manifestations are present without typical symptoms 7, 8

The role of duodenal refluxate in GERD development remains controversial, with bile appearing to play at most a synergistic role with acid rather than an independent causative role, according to the American Gastroenterological Association 9, 10